Theravance Biopharma, Inc.
Developing medicines for specialty respiratory and neurologic diseases like COPD.
TBPH | US
Overview
Corporate Details
- ISIN(s):
- KYG8807B1068
- LEI:
- Country:
- United States of America
- Address:
- UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
- Website:
- https://www.theravance.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Theravance Biopharma, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel medicines. The company focuses on transforming the treatment of specialty respiratory and neurologic diseases. Its core strategy involves an internally discovered pipeline aimed at addressing significant patient needs. A key commercial product is YUPELRI® (revefenacin), an inhalation solution for the treatment of chronic obstructive pulmonary disease (COPD). The company operates under the mission of delivering "Medicines that Make a Difference®" to improve the lives of patients and caregivers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Theravance Biopharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theravance Biopharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theravance Biopharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
